CliffBio
small molecule

ADVIL PM

DIPHENHYDRAMINE CITRATE; IBUPROFEN

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameADVIL PM
Active ingredientDIPHENHYDRAMINE CITRATE; IBUPROFEN
Strength38MG;200MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2005
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.